If confirmed, the cell type-specific SOD3 effect on HIF-2α levels might be of therapeutic use, given the antithetical HIF-2α function in tumorigenesis; its upregulation in cancer cells promotes proliferation and neoangiogenesis15,16 and, in ECs, induces vascular normalization and enhanced drug delivery12,13. The gene discussed is EPAS1; the disease is cancer.